INFRASTRUCTURAL CAPABILITY OF INVESTIGATOR-INITIATED TRIALS INVOLVING UNAPPROVED INVESTIGATIONAL DRUGS IN JAPAN

被引：0
|
作者：
Shimizu, T. [1 ]
Kaneda, H. [1 ]
Tsurutani, J. [1 ]
Okamoto, K. [1 ]
Tanaka, K. [1 ]
Ohnishi, R. [1 ]
Nomura, M. [1 ]
Aida, H.
Hashii, C.
Nakagawa, K. [1 ]
机构：
[1] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt452.2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan
    Tomohisa Sudo
    Akihiro Sato
    Therapeutic Innovation & Regulatory Science, 2017, 51 : 589 - 596
  • [2] Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan
    Sudo, Tomohisa
    Sato, Akihiro
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (05) : 589 - 596
  • [3] INVESTIGATOR-INITIATED CLINICAL TRIALS FOR NEW DRUGS IN JAPAN: CHALLENGES AND PERSPECTIVES
    Katsumata, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 14 - 14
  • [4] International models of investigator-initiated trials: implications for Japan
    Trimble, E. L.
    Ledermann, J.
    Law, K.
    Miyata, T.
    Imamura, C. K.
    Nam, B. -H.
    Kim, Y. H.
    Bang, Y. -J.
    Michaels, M.
    Ardron, D.
    Amano, S.
    Ando, Y.
    Tominaga, T.
    Kurokawa, K.
    Takebe, N.
    ANNALS OF ONCOLOGY, 2012, 23 (12) : 3151 - 3155
  • [5] Investigator-initiated cancer trials with INDs for approval in Japan
    Chiyo K. Imamura
    Naoko Takebe
    Seigo Nakamura
    Hideyuki Saya
    Naoto T. Ueno
    Nature Reviews Clinical Oncology, 2010, 7 : 127 - 128
  • [6] DESIGNING INVESTIGATOR-INITIATED TRIALS
    Rosenfeld, Margaret
    PEDIATRIC PULMONOLOGY, 2012, 47 : 120 - 121
  • [7] MULTICENTER INVESTIGATOR-INITIATED TRIALS
    LENFANT, C
    HARLAN, W
    FRIEDMAN, LM
    CONTROLLED CLINICAL TRIALS, 1989, 10 (02): : 228 - 229
  • [8] Support for Investigator-Initiated Clinical Research Involving Investigational Drugs or Devices: The Clinical and Translational Science Award Experience
    Berro, Marlene
    Burnett, Bruce K.
    Fromell, Gregg J.
    Hartman, Karen A.
    Rubinstein, Eric P.
    Schuff, Kathryn G.
    Speicher, Lisa A.
    ACADEMIC MEDICINE, 2011, 86 (02) : 217 - 223
  • [9] Quality evaluation of investigator-initiated trials using post-approval cancer drugs in Japan
    Kondo, Shunsuke
    Hosoi, Hiroko
    Itahashi, Kota
    Hashimoto, Jun
    CANCER SCIENCE, 2017, 108 (05) : 995 - 999
  • [10] Investigator-initiated trials are more impartial
    Bradley C. Johnston
    Sunita Vohra
    Nature, 2006, 443 : 144 - 144
12345